Literature DB >> 10704053

Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.

N Germain1, E Boichot, J M Planquois, V Lagente.   

Abstract

The aim of the present study was to compare the effects of selective phosphodiesterase (PDE) 3, 4 and 5 inhibitors on antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. When the sensitized guinea-pigs were orally pre-treated with the selective PDE4 inhibitor, Ro 20-1724 (30 mg/kg), and studied 48h after OA, a significant reduction (P<0.01) of the leftward shift of the dose-response curve to ACh was noted, whereas it was ineffective at the lower dose (10 mg/kg). Administration of the selective PDE3 inhibitor, milrinone (30 mg/kg) also elicited a significant reduction (P<0.01) of the airway hyperresponsiveness, whereas the PDE5 inhibitor zaprinast (30 mg/kg) was ineffective. These results show that both PDE3 and PDE4 inhibitors are able to inhibit the antigen-induced airway hyperresponsiveness in sensitized guinea-pigs and support the potential utility of selective PDE inhibitors in the treatment of asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704053      PMCID: PMC1781799          DOI: 10.1080/09629359990487

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  22 in total

1.  Multiple cyclic nucleotide phosphodiesterases.

Authors:  J A Beavo; M Conti; R J Heaslip
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

2.  Bronchial hyperresponsiveness and cellular infiltration in the lung of guinea-pigs sensitized and challenged by aerosol.

Authors:  E Boichot; V Lagente; C Carre; P Waltmann; J M Mencia-Huerta; P Braquet
Journal:  Clin Exp Allergy       Date:  1991-01       Impact factor: 5.018

3.  Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.

Authors:  K F Rabe; H Tenor; G Dent; C Schudt; S Liebig; H Magnussen
Journal:  Am J Physiol       Date:  1993-05

4.  Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.

Authors:  R E Howell; B D Sickels; S L Woeppel
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

5.  Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig.

Authors:  E Boichot; V Lagente; M Paubert-Braquet; N Frossard
Journal:  Neuropeptides       Date:  1993-11       Impact factor: 3.286

6.  Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung.

Authors:  V Lagente; I Moodley; S Perrin; G Mottin; J L Junien
Journal:  Eur J Pharmacol       Date:  1994-04-01       Impact factor: 4.432

7.  Stimulation of alveolar macrophages in asthmatic patients after local provocation test.

Authors:  A B Tonnel; M Joseph; P Gosset; E Fournier; A Capron
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

Review 8.  Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma.

Authors:  K H Banner; C P Page
Journal:  Eur Respir J       Date:  1995-06       Impact factor: 16.671

9.  Regulation by phosphodiesterase isoenzymes of non-adrenergic non-cholinergic contraction in guinea-pig isolated main bronchus.

Authors:  D Spina; S Harrison; C P Page
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors.

Authors:  V Lagente; M P Pruniaux; J L Junien; I Moodley
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.